<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta content="width=device-width, initial-scale=1.0" name="viewport">
  <title>Project Details - Constructo Bootstrap Template</title>
  <meta name="description" content="">
  <meta name="keywords" content="">

  <!-- Favicons -->
  <link href="assets/img/favicon.png" rel="icon">
  <!-- <link href="assets/img/apple-touch-icon.png" rel="apple-touch-icon"> -->

  <!-- Fonts -->
  <link href="https://fonts.googleapis.com" rel="preconnect">
  <link href="https://fonts.gstatic.com" rel="preconnect" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,100;0,300;0,400;0,500;0,700;0,900;1,100;1,300;1,400;1,500;1,700;1,900&family=Lato:ital,wght@0,100;0,300;0,400;0,700;0,900;1,100;1,300;1,400;1,700;1,900&family=Ubuntu:ital,wght@0,300;0,400;0,500;0,700;1,300;1,400;1,500;1,700&display=swap" rel="stylesheet">

  <!-- Vendor CSS Files -->
  <link href="assets/vendor/bootstrap/css/bootstrap.min.css" rel="stylesheet">
  <link href="assets/vendor/bootstrap-icons/bootstrap-icons.css" rel="stylesheet">
  <link href="assets/vendor/aos/aos.css" rel="stylesheet">
  <link href="assets/vendor/swiper/swiper-bundle.min.css" rel="stylesheet">
  <link href="assets/vendor/glightbox/css/glightbox.min.css" rel="stylesheet">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap-icons@1.11.3/font/bootstrap-icons.css">

  <!-- Main CSS File -->
  <link href="assets/css/main.css" rel="stylesheet">

  <!-- =======================================================
  * Template Name: Constructo
  * Template URL: https://bootstrapmade.com/constructo-bootstrap-construction-template/
  * Updated: Aug 30 2025 with Bootstrap v5.3.8
  * Author: BootstrapMade.com
  * License: https://bootstrapmade.com/license/
  ======================================================== -->
</head>

<body class="project-details-page">

  <header id="header" class="header sticky-top">

    <div class="topbar d-flex align-items-center dark-background">
      <div class="container d-flex justify-content-center justify-content-md-between">
        <div class="contact-info d-flex align-items-center">
          <i class="bi bi-envelope d-flex align-items-center"><a href="mailto:contact@example.com">info@myrtace.com</a></i>
          <i class="bi bi-phone d-flex align-items-center ms-4"><span>+91 9710709267</span></i>
        </div>
        <div class="social-links d-none d-md-flex align-items-center">
          <a href="#" class="twitter"><i class="bi bi-twitter-x"></i></a>
          <a href="#" class="facebook"><i class="bi bi-facebook"></i></a>
          <a href="#" class="instagram"><i class="bi bi-instagram"></i></a>
          <a href="#" class="linkedin"><i class="bi bi-linkedin"></i></a>
        </div>
      </div>
    </div><!-- End Top Bar -->

    <div class="branding d-flex align-items-cente">

      <div class="container position-relative d-flex align-items-center justify-content-between">
       <a href="index.html" class="logo d-flex align-items-center">
          <!-- Uncomment the line below if you also wish to use an image logo -->
          <!-- <img src="assets/img/logo.webp" alt=""> -->
         <img src="assets/img/logo.png" alt="MYRTACE Logo" class="site-logo">
        </a>

        <nav id="navmenu" class="navmenu">
          <ul>
            <li><a href="index.html" class="active">Home</a></li>
            <li><a href="about.html">About Us</a></li>
            <li><a href="services.html">Facilities</a></li>
            <li><a href="team.html">Team</a></li>
            <li><a href="contact.html">Contact Us</a></li>
          </ul>
          <i class="mobile-nav-toggle d-xl-none bi bi-list"></i>
        </nav>

      </div>

    </div>

  </header>

  <main class="main">

   
    <!-- Project Details Section -->
    <section id="project-details" class="project-details section">
<div class="container footer-top">
     <header class="mb-5 pb-3 border-bottom border-4 border-deep-blue">
        <h1 class="display-5 text-deep-blue fw-bold">üî¨ Research & Development</h1>
        <p class="lead text-secondary">Advanced Control Strategies for Nitrosamine Impurities</p>
    </header>

    <h2 class="h3 mb-3 text-deep-blue fw-semibold">Nitrosamine Impurities Overview</h2>
    <div class="card p-4 mb-5 shadow-sm custom-blue-bg custom-blue-border">
        <p class="mb-3">We conduct focused, safety-driven R&D on N-nitrosamines and related nitroso impurities to protect patient safety, ensure regulatory compliance and support our customers (API and formulation manufacturers) in managing these compounds across the supply chain.</p>
        <p class="fw-bold mb-3">Our work covers the full lifecycle: <span class="text-primary">Risk Assessment ‚Üí Analytical Method Development ‚Üí Control & Mitigation Strategies ‚Üí Stability & Batch Monitoring ‚Üí Regulatory Documentation.</span></p>
        <p class="text-muted small mt-3">
            <strong class="text-deep-blue">Examples of compounds we study include:</strong> NDMA, NDEA, NEIPA, NDIPA, NDBA, NMBA, NPYR, NPIP, NMOR, NDPA, NDPhA, NMPhA, NEMA, NBnMA, NDBnA, NDELA, NDIBA, NEPhA, DNPIPZ, N-nitrosomethylpropylamine, N-nitrosomethylisopropylamine, N-nitrosomethyl-tert-butylamine, NMU, MNNG, MNPIPZ, NDCYCA, N-nitrosovarenicline, N-nitroso vortioxetine and vortioxetine sulfoxide.
        </p>
    </div>

    <h2 class="h3 mb-4 text-deep-blue fw-semibold">Our R&D Focus Areas</h2>
    <div class="accordion shadow-lg" id="rdFocusAccordion">

        <div class="accordion-item">
            <h2 class="accordion-header" id="headingOne">
                <button class="accordion-button" type="button" data-bs-toggle="collapse" data-bs-target="#collapseOne" aria-expanded="true" aria-controls="collapseOne">
                    1. Risk Assessment & Root-Cause Analysis
                </button>
            </h2>
            <div id="collapseOne" class="accordion-collapse collapse show" aria-labelledby="headingOne" data-bs-parent="#rdFocusAccordion">
                <div class="accordion-body">
                    <ul class="list-unstyled">
                        <li class="mb-2"><i class="bi bi-search text-primary me-2"></i>Systematic risk screening of APIs, intermediates, excipients, solvents, reagents and manufacturing steps that could lead to nitrosamine formation or carry-over.</li>
                        <li class="mb-2"><i class="bi bi-search text-primary me-2"></i>Assessment covers potential sources such as nitrosating agents, amine precursors, solvent/reagent impurities and processing/storage conditions.</li>
                        <li><i class="bi bi-search text-primary me-2"></i>We perform root-cause investigations for any detected nitrosamine to identify origin and corrective actions.</li>
                    </ul>
                    <blockquote class="blockquote-footer mt-2 text-deep-blue">Regulatory expectation: marketing authorization holders must assess nitrosamine risk in products and manufacturing processes.</blockquote>
                </div>
            </div>
        </div>

        <div class="accordion-item">
            <h2 class="accordion-header" id="headingTwo">
                <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo">
                    2. Analytical Method Development & Validation
                </button>
            </h2>
            <div id="collapseTwo" class="accordion-collapse collapse" aria-labelledby="headingTwo" data-bs-parent="#rdFocusAccordion">
                <div class="accordion-body">
                    <ul class="list-unstyled">
                        <li class="mb-2"><i class="bi bi-microscope text-primary me-2"></i>Development and validation of robust, stability-indicating analytical methods for trace-level quantitation (GC/MS, LC-MS/MS and other orthogonal techniques), following regulatory validation principles.</li>
                        <li class="mb-2"><i class="bi bi-microscope text-primary me-2"></i>Emphasis on sensitivity (low ng/g or ng/mL levels where required), method specificity, accuracy, precision and system suitability reporting.</li>
                        <li><i class="bi bi-microscope text-primary me-2"></i>Routine method suitability checks and participation in external proficiency tests where available.</li>
                    </ul>
                    <blockquote class="blockquote-footer mt-2 text-deep-blue">Regulators expect validated methods capable of reliably detecting nitrosamines at or below acceptable intake levels.</blockquote>
                </div>
            </div>
        </div>
        
        <div class="accordion-item">
            <h2 class="accordion-header" id="headingThree">
                <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseThree" aria-expanded="false" aria-controls="collapseThree">
                    3. Establishing Acceptable Intake (AI) & Specification Limits
                </button>
            </h2>
            <div id="collapseThree" class="accordion-collapse collapse" aria-labelledby="headingThree" data-bs-parent="#rdFocusAccordion">
                <div class="accordion-body">
                    <ul class="list-unstyled">
                        <li class="mb-2"><i class="bi bi-ruler text-primary me-2"></i>Use of published AIs and, where appropriate, compound-specific toxicological data, read-across or SAR approaches to derive acceptable intake limits.</li>
                        <li><i class="bi bi-ruler text-primary me-2"></i>When compound-specific AIs are absent, we follow current international approaches (FDA/EMA/ICH/EDQM recommendations) to propose scientifically justified limits.</li>
                    </ul>
                    <blockquote class="blockquote-footer mt-2 text-deep-blue">See FDA and EMA recommended acceptable intake approaches and lists of established AIs.</blockquote>
                </div>
            </div>
        </div>
        
        <div class="accordion-item">
            <h2 class="accordion-header" id="headingFour">
                <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseFour" aria-expanded="false" aria-controls="collapseFour">
                    4. Control & Mitigation Strategies (Quality by Design approach)
                </button>
            </h2>
            <div id="collapseFour" class="accordion-collapse collapse" aria-labelledby="headingFour" data-bs-parent="#rdFocusAccordion">
                <div class="accordion-body">
                    <ul class="list-unstyled">
                        <li class="mb-2"><i class="bi bi-tools text-primary me-2"></i>Process redesign and raw-material controls to eliminate or minimize formation pathways.</li>
                        <li class="mb-2"><i class="bi bi-tools text-primary me-2"></i>Supplier qualification and detailed incoming material testing for amines, nitrite and related precursors.</li>
                        <li class="mb-2"><i class="bi bi-tools text-primary me-2"></i>Specification updates, tightened storage/handling SOPs and change control to prevent new risks.</li>
                        <li><i class="bi bi-tools text-primary me-2"></i>Use of preventive controls and CAPA following detection.</li>
                    </ul>
                    <blockquote class="blockquote-footer mt-2 text-deep-blue">Regulatory guidance expects risk-based controls and supplier management to prevent nitrosamine presence.</blockquote>
                </div>
            </div>
        </div>

        <div class="accordion-item">
            <h2 class="accordion-header" id="headingFive">
                <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseFive" aria-expanded="false" aria-controls="collapseFive">
                    5. Stability, Shelf-Life & Batch Release Monitoring
                </button>
            </h2>
            <div id="collapseFive" class="accordion-collapse collapse" aria-labelledby="headingFive" data-bs-parent="#rdFocusAccordion">
                <div class="accordion-body">
                    <ul class="list-unstyled">
                        <li class="mb-2"><i class="bi bi-calendar-check text-primary me-2"></i>Longitudinal monitoring of retained samples to evaluate nitrosamine formation over shelf life and under stress/storage conditions.</li>
                        <li class="mb-2"><i class="bi bi-calendar-check text-primary me-2"></i>Batch release includes nitrosamine screening where risk assessment indicates potential presence.</li>
                        <li><i class="bi bi-calendar-check text-primary me-2"></i>Ongoing surveillance and trending to detect shifts in impurity profiles.</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="accordion-item">
            <h2 class="accordion-header" id="headingSix">
                <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseSix" aria-expanded="false" aria-controls="collapseSix">
                    6. Regulatory Dossiers, Reporting & Support
                </button>
            </h2>
            <div id="collapseSix" class="accordion-collapse collapse" aria-labelledby="headingSix" data-bs-parent="#rdFocusAccordion">
                <div class="accordion-body">
                    <ul class="list-unstyled">
                        <li class="mb-2"><i class="bi bi-file-earmark-text text-primary me-2"></i>Preparation of risk assessment reports, method validation packages and corrective action documents for regulatory submissions and inspections.</li>
                        <li class="mb-2"><i class="bi bi-file-earmark-text text-primary me-2"></i>Support for dossier updates, variations and responses to regulatory queries.</li>
                        <li><i class="bi bi-file-earmark-text text-primary me-2"></i>We align documentation to ICH M7 principles and regional positions (FDA, EMA, EDQM).</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="accordion-item">
            <h2 class="accordion-header" id="headingSeven">
                <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseSeven" aria-expanded="false" aria-controls="collapseSeven">
                    7. Safety, Handling & Lab Controls
                </button>
            </h2>
            <div id="collapseSeven" class="accordion-collapse collapse" aria-labelledby="headingSeven" data-bs-parent="#rdFocusAccordion">
                <div class="accordion-body">
                    <ul class="list-unstyled">
                        <li class="mb-2"><i class="bi bi-shield-lock-fill text-primary me-2"></i>Strict laboratory safety, chemical hygiene and waste-management practices for working with nitroso compounds and suspected precursors.</li>
                        <li><i class="bi bi-shield-lock-fill text-primary me-2"></i>Personnel receive targeted training on hazard awareness, sample handling and emergency procedures.</li>
                    </ul>
                    <blockquote class="blockquote-footer mt-2 text-deep-blue">(This section on safety is deliberately non-procedural ‚Äî it does not provide operational steps).</blockquote>
                </div>
            </div>
        </div>
        
        <div class="accordion-item">
            <h2 class="accordion-header" id="headingEight">
                <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#collapseEight" aria-expanded="false" aria-controls="collapseEight">
                    8. Collaboration & Scientific Transparency
                </button>
            </h2>
            <div id="collapseEight" class="accordion-collapse collapse" aria-labelledby="headingEight" data-bs-parent="#rdFocusAccordion">
                <div class="accordion-body">
                    <ul class="list-unstyled">
                        <li class="mb-2"><i class="bi bi-people-fill text-primary me-2"></i>Collaborative work with toxicologists, regulatory experts and external laboratories to keep approaches aligned with global best practice.</li>
                        <li><i class="bi bi-people-fill text-primary me-2"></i>Publication and sharing of non-confidential method performance summaries and risk-assessment frameworks with clients on request.</li>
                    </ul>
                </div>
            </div>
        </div>
    </div>

    <hr class="my-5 border border-2 border-primary opacity-75">

    <div class="row g-4">
        <div class="col-lg-7">
            <h3 class="h4 mb-3 text-deep-blue fw-semibold">ü§ù What We Offer to Clients / Partners</h3>
            <div class="p-3 border rounded shadow-sm">
                <ul class="list-group list-group-flush">
                    <li class="list-group-item"><i class="bi bi-chevron-right text-primary me-2"></i>Comprehensive nitrosamine risk assessments for APIs and finished products.</li>
                    <li class="list-group-item"><i class="bi bi-chevron-right text-primary me-2"></i>Development and validation of trace-level analytical methods (sensitivity and robustness reporting).</li>
                    <li class="list-group-item"><i class="bi bi-chevron-right text-primary me-2"></i>Supplier audits and incoming-material qualification focused on nitrosamine precursors.</li>
                    <li class="list-group-item"><i class="bi bi-chevron-right text-primary me-2"></i>Root-cause investigations and CAPA implementation following any detection.</li>
                    <li class="list-group-item"><i class="bi bi-chevron-right text-primary me-2"></i>Regulatory-grade documentation: AI justification, control strategy, method validation, stability data.</li>
                    <li class="list-group-item"><i class="bi bi-chevron-right text-primary me-2"></i>Retained-sample monitoring programs and shelf-life surveillance.</li>
                    <li class="list-group-item"><i class="bi bi-chevron-right text-primary me-2"></i>Customized training for manufacturing and QA/QC teams on nitrosamine risk awareness.</li>
                </ul>
            </div>
        </div>

        <div class="col-lg-5">
            <h3 class="h4 mb-3 text-deep-blue fw-semibold">‚úÖ Why Choose Our R&D Team</h3>
            <div class="p-3 border rounded shadow-sm custom-blue-bg">
                <ul class="list-group list-group-flush bg-transparent">
                    <li class="list-group-item bg-transparent"><i class="bi bi-check-lg text-deep-blue me-2"></i><strong class="text-deep-blue">Regulatory-aware:</strong> Programs aligned with FDA, EMA, ICH and EDQM expectations.</li>
                    <li class="list-group-item bg-transparent"><i class="bi bi-check-lg text-deep-blue me-2"></i><strong class="text-deep-blue">Analytical Expertise:</strong> Trace-level LC-MS/MS and GC-MS workflows.</li>
                    <li class="list-group-item bg-transparent"><i class="bi bi-check-lg text-deep-blue me-2"></i><strong class="text-deep-blue">Cross-functional:</strong> Toxicology, chemistry, QA/RA, and analytics under one roof.</li>
                    <li class="list-group-item bg-transparent"><i class="bi bi-check-lg text-deep-blue me-2"></i><strong class="text-deep-blue">Confidential & Audit-ready</strong> documentation.</li>
                </ul>
            </div>
        </div>
    </div>

    <hr class="my-5 border border-2 border-primary opacity-75">

    <div class="row g-4">
        <div class="col-lg-8">
            <h3 class="h4 mb-3 text-deep-blue fw-semibold">üìö Important Regulatory References</h3>
            <ul class="list-group shadow-sm">
                <li class="list-group-item d-flex justify-content-between align-items-center">
                    FDA ‚Äî Control of Nitrosamine Impurities in Human Drugs (Guidance for Industry).
                    <span class="badge bg-primary text-white rounded-pill">U.S. FDA</span>
                </li>
                <li class="list-group-item d-flex justify-content-between align-items-center">
                    FDA ‚Äî Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities.
                    <span class="badge bg-primary text-white rounded-pill">U.S. FDA</span>
                </li>
                <li class="list-group-item d-flex justify-content-between align-items-center">
                    EMA ‚Äî Nitrosamine impurities: guidance and updates for marketing-authorisation holders.
                    <span class="badge bg-primary text-white rounded-pill">EMA</span>
                </li>
                <li class="list-group-item d-flex justify-content-between align-items-center">
                    ICH M7(R2) and addendum ‚Äî Assessment and control of DNA-reactive (mutagenic) impurities.
                    <span class="badge bg-primary text-white rounded-pill">ICH</span>
                </li>
                <li class="list-group-item d-flex justify-content-between align-items-center">
                    EDQM / Europe updates on N-nitrosamines and Acceptable Intakes.
                    <span class="badge bg-primary text-white rounded-pill">EDQM</span>
                </li>
            </ul>
        </div>

        <div class="col-lg-4">
            <h3 class="h4 mb-3 text-deep-blue fw-semibold">üìû Contact & Requests</h3>
            <div class="card border-primary text-center p-4 shadow">
                <p class="card-text">For technical discussions, to request a risk assessment, COA/MSDS, or to arrange a confidential consultation about nitrosamine control, please contact:</p>
                <a href="mailto:rnd@example.com" class="btn btn-primary btn-lg mt-3 fw-bold">R&D & Technical Enquiries</a>
            </div>
        </div>
    </div>

</div>
</div>

    </section><!-- /Project Details Section -->

  </main>

  <footer id="footer" class="footer dark-background">

    <div class="container footer-top">
      <div class="row gy-4">
        <div class="col-lg-5 col-md-12 footer-about">
          <a href="index.html" class="logo d-flex align-items-center">
          <!-- Uncomment the line below if you also wish to use an image logo -->
          <!-- <img src="assets/img/logo.webp" alt=""> -->
         <img src="assets/img/logo.png" alt="MYRTACE Logo" class="site-logo">
        </a>
          <p>With 15 years of excellence, we deliver certified pharma raw materials to manufacturing units, ensuring purity, consistency and on-time supply.</p>
          <div class="social-links d-flex mt-4">
            <a href=""><i class="bi bi-twitter-x"></i></a>
            <a href=""><i class="bi bi-facebook"></i></a>
            <a href=""><i class="bi bi-instagram"></i></a>
            <a href=""><i class="bi bi-linkedin"></i></a>
          </div>
        </div>

        <div class="col-lg-2 col-6 footer-links">
          <h4>Useful Links</h4>
          <ul>
            <li><a href="/OurClients.html">Our Clients</a></li>
            <li><a href="/ManufacturingFacilities.html">Manufacturing Facilities</a></li>
            <li><a href="/CareerPage.html">Career page</a></li>
            <li><a href="/T&C.html">Terms and Condition</a></li>
            <li><a href="PrivacyPolicy.html">Privacy Policy</a></li>
            <li><a href="Product.html">Products</a></li>
             <li><a href="/QC.html">Quality Control</a></li>
              <li><a href="/ContractManufacturing.html">Contract Manufacturing / third party Manufacturing</a></li>
               <li><a href="/Disclaimer.html">Disclaimer</a></li>
          </ul>
        </div>

        <div class="col-lg-2 col-6 footer-links">
          <h4>Our Services</h4>
          <ul>
            <li><a href="/Blog.html">Blogs / knowlwdge center</a></li>
            <li><a href="/research&development.html">Research & Development</a></li>
            <li><a href="#">Downloads</a></li>
            <li><a href="#">Investor relation</a></li>
            <li><a href="#">Financial Report</a></li> 
            <li><a href="#">Board meetings</a></li> 
            <li><a href="#">Share Holder Information</a></li> 
            <li><a href="#">News & Update / Press release</a></li> 
            <li><a href="/Work Culture&HRPolicy.html">Work Culture & HR policy</a></li>
          </ul>
        </div>

        <div class="col-lg-3 col-md-12 footer-contact text-center text-md-start">
          <h4>Contact Us</h4>
          <p>Myrtace Healthcare Private Limited</p>
          <p>Research and Development Centre</p>
          <p>Plot No. 29, SIPCOT Phase II</p>
          <p>Hosur, Tamil Nadu, India</p>
          <p class="mt-4"><strong>Phone:</strong> <span>+91 9710709267</span></p>
          <p><strong>Email:</strong> <span>info@myrtace.com</span></p>
        </div>

      </div>
    </div>

    <div class="container copyright text-center mt-4">
      <p>¬© <span>Copyright</span> <strong class="px-1 sitename">Constructo</strong> <span>All Rights Reserved</span></p>
      <div class="credits">
        <!-- All the links in the footer should remain intact. -->
        <!-- You can delete the links only if you've purchased the pro version. -->
        <!-- Licensing information: https://bootstrapmade.com/license/ -->
        <!-- Purchase the pro version with working PHP/AJAX contact form: [buy-url] -->
        Designed by <a href="www.kavinindia.com"><strong>Kavin India Pvt Ltd.</strong></a>
      </div>
    </div>

  </footer>

  <!-- Scroll Top -->
  <a href="#" id="scroll-top" class="scroll-top d-flex align-items-center justify-content-center"><i class="bi bi-arrow-up-short"></i></a>

  <!-- Preloader -->
  <div id="preloader"></div>

  <!-- Vendor JS Files -->
  <script src="assets/vendor/bootstrap/js/bootstrap.bundle.min.js"></script>
  <script src="assets/vendor/php-email-form/validate.js"></script>
  <script src="assets/vendor/aos/aos.js"></script>
  <script src="assets/vendor/swiper/swiper-bundle.min.js"></script>
  <script src="assets/vendor/glightbox/js/glightbox.min.js"></script>

  <!-- Main JS File -->
  <script src="assets/js/main.js"></script>

</body>

</html>